Michigan Cornea Consultants, PC Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2011
NCT01393132
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Michigan Cornea Consultants, P.C.